Monitoring of human papillomavirus vaccination

Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

2003 • 6,072 citations

Papillomaviruses and cancer: from basic studies to clinical application

2002 • 3,873 citations

Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions

2007 • 2,003 citations

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

2007 • 1,820 citations

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

2006 • 1,766 citations

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

2004 • 1,624 citations

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

2009 • 1,580 citations

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

2002 • 1,570 citations

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

2005 • 1,551 citations

Chapter 2: The burden of HPV-related cancers

2006 • 1,374 citations

Against which human papillomavirus types shall we vaccinate and screen? the international perspective

2004 • 1,099 citations

Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University Students

2003 • 1,048 citations

A Cohort Study of the Risk of Cervical Intraepithelial Neoplasia Grade 2 or 3 in Relation to Papillomavirus Infection

1992 • 952 citations

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study

2001 • 814 citations

Carcinogenicity of human papillomaviruses

2005 • 678 citations

Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection

2007 • 652 citations

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

2009 • 626 citations

Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine

2001 • 605 citations

Comparison of Human Papillomavirus Types 16, 18, and 6 Capsid Antibody Responses Following Incident Infection

2000 • 561 citations

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

2004 • 541 citations

Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease

2006 • 527 citations

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles

1991 • 511 citations

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

2006 • 453 citations

Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

2006 • 452 citations

A Virus-Like Particle Enzyme-Linked Immunosorbent Assay Detects Serum Antibodies in a Majority of Women Infected With Human Papillomavirus Type 16

1994 • 394 citations

Evaluating Human Papillomavirus Vaccination Programs

2004 • 388 citations

The Natural History of Human Papillomavirus Type 16 Capsid Antibodies among a Cohort of University Women

1996 • 335 citations

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1998 • 326 citations

Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses

2006 • 286 citations

Minor Capsid Protein of Human Genital Papillomaviruses Contains Subdominant, Cross-Neutralizing Epitopes

2000 • 245 citations

Vaccination against colonizing bacteria with multiple serotypes

1997 • 242 citations

Role of Herd Immunity in Determining the Effect of Vaccines against Sexually Transmitted Disease

2005 • 241 citations

Cost-Effectiveness of Male Circumcision for HIV Prevention in a South African Setting

2006 • 239 citations

The Theoretical Population-Level Impact of a Prophylactic Human Papilloma Virus Vaccine

2002 • 233 citations

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

2009 • 228 citations

The serological response to papillomaviruses

1999 • 225 citations

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women

2009 • 223 citations

Impact of HPV infection in adolescent populations

2005 • 221 citations

Efficacy and other milestones for human papillomavirus vaccine introduction

2004 • 214 citations

Natural History of Human Papillomavirus Type 16 Virus-Like Particle Antibodies in Young Women

2004 • 194 citations

A Phase 1 Study of a Recombinant Viruslike Particle Vaccine against Human Papillomavirus Type 11 in Healthy Adult Volunteers

2001 • 193 citations

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

2008 • 189 citations

Therapeutic human papillomavirus vaccines: current clinical trials and future directions

2008 • 188 citations

Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition

1996 • 179 citations

Seropositivities to Human Papillomavirus Types 16, 18, or 33 Capsids and to Chlamydia trachomatis Are Markers of Sexual Behavior

1996 • 172 citations

HPV-mediated transformation of the anogenital tract

2005 • 170 citations

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines

2009 • 165 citations

The challenges of organising cervical screening programmes in the 15 old member states of the European Union

2009 • 163 citations

HPV infection in Europe

2009 • 163 citations

Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes

2006 • 163 citations

The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes

1991 • 152 citations

Cervical Coinfection with Human Papillomavirus (HPV) Types and Possible Implications for the Prevention of Cervical Cancer by HPV Vaccines

2005 • 151 citations

Chlamydia trachomatis infection and persistence of human papillomavirus

2005 • 151 citations

Burden of cervical cancer in Europe: estimates for 2004

2007 • 140 citations

Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer

1997 • 138 citations

Common Neutralization Epitope in Minor Capsid Protein L2 of Human Papillomavirus Types 16 and 6

1999 • 134 citations

Delivering on the promise: HPV vaccines and cervical cancer

2004 • 127 citations

Characterization of a Major Neutralizing Epitope on Human Papillomavirus Type 16 L1

1999 • 120 citations

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention

2008 • 115 citations

NHPV16 VLP Vaccine Induces Human Antibodies That Neutralize Divergent Variants of HPV16

2001 • 112 citations

Immunogenicity Testing in Human Papillomavirus Virus‐Like‐Particle Vaccine Trials

2009 • 109 citations

Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination

2005 • 107 citations

Development of therapeutic HPV vaccines

2009 • 101 citations

Review of current knowledge on HPV vaccination: An Appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening

2007 • 96 citations

A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine

2004 • 94 citations

Occurrence of Cervical Infection with Multiple Human Papillomavirus Types is Associated with Age and Cytologic Abnormalities

2003 • 89 citations

HPV type-specific risks of high-grade CIN during 4 years of follow-up: A population-based prospective study

2007 • 89 citations

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland

2007 • 86 citations

Neutralization of Human Papillomavirus Type 11 (HPV‐11) by Serum from Women Vaccinated with Yeast‐Derived HPV‐11 L1 Virus‐like Particles: Correlation with Competitive Radioimmunoassay Titer

2001 • 82 citations

Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006–January 2008

2008 • 79 citations

Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix.

1997 • 78 citations

Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing

2006 • 77 citations

Results of the First World Health Organization International Collaborative Study of Detection of Human Papillomavirus DNA

2006 • 76 citations

Chapter 16: Prophylactic Human Papillomavirus Vaccines

2003 • 64 citations

Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses

2005 • 61 citations

Prevaccination Distribution of Human Papillomavirus Types in Women Attending at Cervical Cancer Screening in Belgium

2009 • 60 citations

Chapter 17: Second generation HPV vaccines to prevent cervical cancer

2006 • 57 citations

Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15–25 years of age

2008 • 57 citations

Chimeric papillomavirus virus-like particles induce a murine self-antigen-specific protective and therapeutic antitumor immune response

1999 • 56 citations

Dendritic cells: the host Achille's heel for mucosal pathogens?

2004 • 55 citations

Human papillomaviruses biochemical and biologic properties

1985 • 55 citations

The current state of introduction of HPV vaccination into national immunisation schedules in Europe: Results of the VENICE 2008 survey

2009 • 51 citations

Correlates of the spread of human papillomavirus infection.

2000 • 50 citations

Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction

2001 • 49 citations

Progress in prophylactic and therapeutic vaccines for human papillomavirus infection

2003 • 49 citations

What’s next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination

2009 • 48 citations

Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacy

2006 • 37 citations

Role of Conformational Epitopes Expressed by Human Papillomavirus Major Capsid Proteins in the Serologic Detection of Infection and Prophylactic Vaccination

1994 • 30 citations

Human cellular immune responses against human papillomaviruses in cervical neoplasia

1998 • 30 citations

Seroepidemiology as basis for design of a human papillomavirus vaccination program

2008 • 29 citations

Introduction of human papillomavirus (HPV) vaccination in Sweden

2009 • 26 citations

Introduction of Human Papillomavirus Vaccination in Belgium, Luxembourg and the Netherlands

2010 • 13 citations

Statement on human papillomavirus DNA test utilization.

2009 • 12 citations

Statement on Human Papillomavirus DNA Test Utilization

2009 • 7 citations

Recent developments in human papillomavirus vaccines

2004 • 6 citations

Preparations for implementing human papillomavirus vaccination should begin

2005 • 3 citations

Deleted Work

1955 • 0 citations